HTAi Policy Forum Series
Global Policy Forum

Policy Forum Members

For-profit Organizations 

  1. Abbott Vascular International BVBA
  2. AMGEN (Europe) GmbH
  3. AstraZeneca (UK) Ltd
  4. Boehringer Ingelheim
  5. Boston Scientific Corporation
  6. Bristol-Myers Squibb
  7. Edwards Lifesciences
  8. Eli Lilly and Company
  9. F. Hoffmann-La Roche AG
  10. GlaxoSmithKline
  11. Johnson & Johnson
  12. Medtronic
  13. Merck & Co
  14. Merck KGaA
  15. Novartis Pharma AG
  16. Pfizer Limited
  17. Sanofi Genzyme
  18. W. L. Gore & Associates

Not-for-profit organizations

  1. BCBSA – Blue Cross Blue Shield Association (USA)
  2. CADTH – Canadian Agency for Drugs and Technologies in Health (Canada)
  3. CMTP – Center for Medical Technology Policy (USA)
  4. CONITEC – National Committee for Technology Incorporation (Brazil)
  5. HAS – French National Authority for Health (France)
  6. Healthcare Improvement Scotland (UK)
  7. HTAA – Health Technology Assessment Association (Russia)
  8. ICER – Institute for Clinical & Economic Review (USA)
  9. IQWiG – Institute for Quality and Efficiency in Health Care (Germany)
  10. Kaiser Permanente (USA)
  11. NECA – National Evidence-based Healthcare Collaborating Agency (South Korea)
  12. NICE – National Institute for Health and Care Excellence (UK)
  13. NIPHNO – Norwegian Institute of Public Health Norway (Norway)
  14. PBAC & MSAC Australia Government, Department of Health and Ageing (Australia)
  15. PCORI – Patient-Centered Outcomes Research Institute (USA)
  16. Swedish Council on HTA (SBU) and Swedish Dental and Pharmaceutical Benefits Agency (TLV) – joint membership (Sweden)
  17. ZINL – National Health Care Institute (Netherlands)
  18. AQuaS – Agency of Health Quality and Assessment of Catalonia (Spain)
  19. BC Cancer (Canada)
  20. IETS – Institute of Technological Evaluation in Health (Colombia)